News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lund-Hansen Torben
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/30/2023 |
4
| Lund-Hansen Torben (SVP & CHIEF TECHNICAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 32,000 options to buy
@ $4.55, valued at
$145.6k
|
|
| 01/19/2023 |
4
| Lund-Hansen Torben (SVP & CHIEF TECHNICAL OFFICER) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 17,800 shares
@ $0
Granted 35,700 options to buy
@ $4.7, valued at
$167.8k
|
|
| 04/28/2022 |
4
| Lund-Hansen Torben (SVP & CTO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.51, valued at
$190.2k
|
|
| 12/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2020 |
4
| Lund-Hansen Torben (SVP & CTO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $53.88, valued at
$1.1M
|
|
| 12/11/2019 |
4
| Lund-Hansen Torben (Sr. VP & CTO) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $33.74, valued at
$674.8k
|
|
| 12/13/2018 |
4
| Lund-Hansen Torben (Sr VP & Head of Technical Oper) has filed a Form 4 on Y-mAbs Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $21.97, valued at
$439.4k
|
|
|
|